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nfectiousness. The occurrence, severity and duration of
ymptoms are predictive factors of clinical deterioration.
e report here the epidemiological, clinical, virological and
mmunological characteristics of a cohort of patients with
HI.
Methods: Prospective observational study of patients
ith PHI at the Emilio Ribas Institute of Infectious Dis-
ases, a tertiary hospital in Sao Paulo, Brazil. Inclusion
riteria included negative or undetermined HIV-1 serology
ssociated with viral detection, or clinical and serological
vidence of seroconversion during the last 6 months. Epi-
emiological history, clinical data, HIV-1 plasma viral load,
D4 cell count, genotypic resistance testing, serology for
epatitis B, C, A, toxoplasmosis, cytomegalovirus, herpes
nd syphilis were recorded as well as the use of highly active
ntiretroviral treatment (HAART).
Results: Between 2007 and 2009, 10 patients met the
nclusion criteria (8 males and 2 females, median age
as 34). Two patients were asymptomatic and eight were
ymptomatic. The main symptoms were fever (80%), myal-
ia (60%), rash (30%), hepatitis (20%) aseptic meningitis
20%) and renal failure (10%). Only 4 patients had a
ononucleosis-like illness. Homosexual transmission route
as more frequent (60%). Five patients had plasma viral
oad above the upper limit of detection and the median
D4 cell count was 395cel/mm+ (range: 47—835cel/mm+).
ive patients received HAART and among 5 patients who
id not receive HAART, 2 patients had clinical and immuno-
ogical criteria for initiating HAART after 12 months of
ollow-up. Genotypic resistance testing was available for 4
atients. Overall patients had triple class susceptible HIV-
sub-type B strain. One patient had primary resistance to
on-nucleoside reverse transcriptase inhibitors and several
rotease inhibitors mutations and this ﬁnding was correlated
ith clinical severity.
Conclusion: Clinical, virological and immunological
arameters in PHI may be heterogenous, atypical clinical
resentation is frequent. Determinating resistance proﬁle is
seful for early therapeutic intervention, which is associated
ith better outcome.
oi:10.1016/j.ijid.2010.02.1657
7.022
revalence of metabolic syndrome and estimated Fram-
ngham risk score among Brazilian HIV-infected patients
. Margareth1,∗, E.L. Dorea2, I.M. Bensenor3, I.R.S.
liveira2, G.A. Pinto2, A.L. Sassaki 2, P.A. Lotufo3
Instituto de Infectologia Emílio Ribas, Sao Paulo, Brazil
Hospital Universitário, University of Sao Paulo, Sao Paulo,
razil
Faculdade de Medicina, University of Sao Paulo, Sao Paulo,
razil
Background: Recent studies suggest that HIV infection
tself or combination ART (cART) were both associated with
ncreased risk for cardiovascular disease (CVD). The 10-year
ramingham risk score (FRS) is used to predict cardiovascular
vents in the non-HIV-infected patients, and its applica-
ion in the HIV-infected subjects is under discussion. We
valuated the traditional CVD risk factors and metabolic
s
g
s
aternational Congress on Infectious Diseases (ICID) Abstracts
yndrome (MS) components among HIVinfected patients ART-
reated and ART-naïve.
Methods: This was a cross-sectional study of HIV-infected
ubjects ART-treated (n = 29), HIVinfected patients ART-
aive (n = 28) and controls without previous CVD events
n = 32). Subjects were selected for common age range
20 to 69 years) from the Instituto de Infectologia Emilio
ibas, São Paulo. We assessed cardiovascular risk factors,
IV viral load, nadir CD4 count, high-sensivity C-reactive
rotein (hs-CRP) and plasma lipid concentrations. MS compo-
ents included low LDL cholesterol, high triglycerides, high
MI, hypertension and diabetes. The statistical analysis were
one using a SPSS 16.0.
Results: Groups were matched for age (mean 43.6 years
or ART-treated vs 42.0 years for ART-naïve vs 42.8 for con-
rols); 31%, 35.7% o and 46.8% are women, respectively.
he mean duration of HIV infection was 10 years for ART-
reated and 6 years for ART-naïve subjects. The mean nadir
D4 count (cells/L) was 208 for ART-treated and 449
or ARTnaïve subjects (p < 0.0001); current HIV-RNA levels
ere undetectable on ART-treated and 13.683 copies/ml on
RT-naïve subjects (p = 0.005). There were no signiﬁcant dif-
erences between the groups in levels of hs-CRP, HDL and
DL-cholesterol. Total cholesterol was higher in ART-treated
han in ART-naïve (mean 209 vs 182mg/dl, respectively;
= 0.02); triglycerides was higher in ART-treated than in
RT-naïve subjects (mean 234 vs 137mg/dl, respectively;
= 0.02). Hypertension was more frequent in ART-treated
ompared to the others groups (p = 0.01). 41.4% of ART-
reated patients had MS, compared to 25% of ARTnaïve and
8.1% of controls (p = 0.0001); 27.6% of ART-treated had a
igh (> 20%) 10-year FRS compared to 0% in the others groups
p < 0.0001).
Conclusion: Our results shows a high prevalence of MS
nd high FRS in HIV-patients under treatment, which can
e used to predict cardiovascular risk stratiﬁcation in this
opulation.
oi:10.1016/j.ijid.2010.02.1658
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actors affecting acceptance of HIV testing among ante-
atal care attendees in Ethiopia: With emphasis on role
f male partners
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Background: Counselling and testing is an entry point for
MTCT of HIV infection. To increase uptake of PMTCT inter-
entions and to beneﬁt more generally from HIV testing, the
reater involvement of men is important. This study was
esigned to assess factors affecting acceptance of HIV test-
ng among antenatal care (ANC) attendees with emphasis on
ole of male partners, in Wolaita zone, southern Ethiopia.
Methods: Cross-sectional study was conducted on 412
regnant women using structured questionnaire from March
o April 2008 in three public health centers of Wolaita zone,
outhern Ethiopia. The study was complimented and trian-
ulated by focus group discussions (FGDs). In the absence of
imilar study, the sample size was determined based on the
ssumption that 50% of women would make joint (with their
